Learn More
Medchemexpress LLC SR9011 hydrochloride | 2070014-94-5 | 98.97% | 515.50 | 100 MG

Supplier: Medchemexpress LLC HY16988A100MG
SR9011 hydrochloride is a REV-ERBα/β agonist with IC50s of 790 nM and 560 nM for REV-ERBα and REV-ERBβ, respectively. It is for research use only.
- Increases REV-ERB-dependent repressor activity.
- Suppresses proliferation of breast cancer cell lines, regardless of ER or HER2 status.
- Causes cell cycle arrest prior to M phase by suppressing Cyclin A (CCNA2).
- Suppresses the expression of BMAL1 mRNA in HepG2 cells in a REV-ERBα/β-dependent manner.
- Displays reasonable plasma exposure in vivo.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.